Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471

News
2021
2020
Archive

December 16, 2020

Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
December 15, 2020

NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020

Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz as Executive Vice President of Technical Operations
December 14, 2020

Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
December 11, 2020

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD)
December 8, 2020

Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes™ Trial of DSG3-CAART for Treatment of Mucosal-Dominant Pemphigus Vulgaris
December 8, 2020

Enliven Therapeutics Launches with Vision of Advancing Medicine and Restoring Lives
December 8, 2020

Pear Therapeutics Completes $80M Series D Financing Led By SoftBank Vision Fund 2
December 8, 2020

Entrada Therapeutics Strengthens Leadership Team with Key Appointments
December 7, 2020

Artiva Biotherapeutics Announces FDA Allowance of IND to Initiate Clinical Trials of AB-101 in Combination with Rituximab for the Treatment of Advanced B-cell Lymphomas

1
2
3
…
14
Next Page »

© 2021 5AM Venture Management LLC